Clinical Trial Update: People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on people with chronic hepatitis C who achieved sustained virological response after direct-acting antiviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Diabetes Mellitus
• Hepatitis C

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes Mellitus, Hepatitis C, Chronic | Phase 4 | Status: ACTIVE_NOT_RECRUITING